IT1276453B1 - Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego. - Google Patents

Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego.

Info

Publication number
IT1276453B1
IT1276453B1 IT95TO000545A ITTO950545A IT1276453B1 IT 1276453 B1 IT1276453 B1 IT 1276453B1 IT 95TO000545 A IT95TO000545 A IT 95TO000545A IT TO950545 A ITTO950545 A IT TO950545A IT 1276453 B1 IT1276453 B1 IT 1276453B1
Authority
IT
Italy
Prior art keywords
helycobacter
pylori
preparation
therapeutic compositions
protein
Prior art date
Application number
IT95TO000545A
Other languages
English (en)
Inventor
Peter William Dettmar
Andrew William Smith
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ITTO950545A0 publication Critical patent/ITTO950545A0/it
Publication of ITTO950545A1 publication Critical patent/ITTO950545A1/it
Application granted granted Critical
Publication of IT1276453B1 publication Critical patent/IT1276453B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

E' descritta una proteina di Helycobacter pylori, denominata HAP (emayglutinina/proteasi) come soggetto appropriato per un peptide/proteina vaccino o composizione terapeutica per prevenire contro l'infezione da H. pylori. Siti antigenici della proteina HAP di H. pylori, che determinano risposte anticorporali in pazienti includono la regione di legame con lo zinco e il sito attivo di proteasi.
IT95TO000545A 1994-06-29 1995-06-29 Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego. IT1276453B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413073A GB2290710B (en) 1994-06-29 1994-06-29 Protease from helicobacter pylori for use in vaccines/therapeutic compositions

Publications (3)

Publication Number Publication Date
ITTO950545A0 ITTO950545A0 (it) 1995-06-29
ITTO950545A1 ITTO950545A1 (it) 1996-12-29
IT1276453B1 true IT1276453B1 (it) 1997-10-31

Family

ID=10757523

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95TO000545A IT1276453B1 (it) 1994-06-29 1995-06-29 Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego.

Country Status (3)

Country Link
DE (1) DE19523554A1 (it)
GB (1) GB2290710B (it)
IT (1) IT1276453B1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0935965A4 (en) * 1996-04-23 2002-01-23 Toray Industries SUBSTANCE AGAINST PYLORI

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
WO1993016723A1 (en) * 1992-02-26 1993-09-02 Vanderbilt University Purified vacuolating toxin from helicobacter pylori and methods to use same
EP0967279B1 (en) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori cytotoxin useful for vaccines and diagnostics

Also Published As

Publication number Publication date
GB2290710B (en) 1998-03-25
ITTO950545A1 (it) 1996-12-29
ITTO950545A0 (it) 1995-06-29
GB2290710A (en) 1996-01-10
DE19523554A1 (de) 1996-01-04
GB9413073D0 (en) 1994-08-17

Similar Documents

Publication Publication Date Title
EA200601132A1 (ru) Предупреждение и лечение амилоидогенного заболевания
TR199802423T2 (xx) Konsantre antikor terkibi.
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
EP0824915A3 (de) Herstellung von Glycoglycerolipiden, deren Verwendung als Tenside sowie kosmetische oder dermatologische Zubereitungen, solche Glycoglycerolipide enthaltend
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
FR2792202B1 (fr) Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
EE9400356A (et) Polüetüleenglükool proteiin konjugaadid, ühendid, nende kasutamine, meetod konjugaatide valmistamiseks ja ravimvormid
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
DK0858504T3 (da) Diagnostiske midler mod og behandlinger af periodontale sygdomme
DK1079803T3 (da) Proteinholdige præparater
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
BR0211186A (pt) peptìdeos e uso dos mesmos no escurecimento da pele
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
FI913100A0 (fi) Farmaceutiska preparat.
FR2857597B1 (fr) Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
GB9501826D0 (en) Polypeptide fragments
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE338819T1 (de) Antigenes protein aus malassezia
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도

Legal Events

Date Code Title Description
0001 Granted